- Novavax COVID-19 vaccine gets emergency use authorization in US
- FDA Fast Track Designation = Immediate Surge in Stock Prices?
- France Resumes COVID-19 Vaccination Campaign
- Why did Early American Settlers stuggling with “Prairie Madness”?
- Largest Healthcare Group in the US Initiates Strike
- Targeting Sugar Molecules in Sugar-Immune Therapy
Pfizer vaccines: Allergic reactions occurred within two minutes after injection
Pfizer vaccines: Allergic reactions occurred within two minutes after injection. Pfizer: Two cases of allergic reactions occurred within two minutes after the vaccine injection. According to CNBC news, the US Food and Drug Administration (FDA) has approved Pfizer/BioNTech’s emergency use authorization application for the COVID-19 vaccine.
According to a CNN report, on December 11, local time, a representative of Pfizer Pharmaceuticals stated that two British medical staff had an adverse reaction within a few minutes after being vaccinated with Pfizer/BioNTech’s COVID-19 vaccine.
It is reported that the two medical staff have a history of severe allergies and have recovered.
Dr. Susan Mather, Pfizer’s senior director of security monitoring and risk management, told the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices on Friday: “The responses of these two women were all within minutes. It started. It’s about two minutes, some say it’s a few minutes.”
On Friday, the Immunization Practice Advisory Committee held a half-day meeting to discuss the Pfizer/BioNTech Covid-19 vaccine, and then, at a follow-up meeting, it will vote on whether certain groups should not be vaccinated with Pfizer’s COVID-19 vaccine.
After these two cases occurred in the UK, the British health authorities made preventive recommendations that people with a history of severe allergies should not get the vaccine.